Kivo Health was founded with the mission to revolutionize the treatment of chronic lung diseases through telehealth solutions. Their core vision is to make life-changing pulmonary rehabilitation accessible to all eligible patients. Kivo Health offers an 8-week clinical program led by live therapists, designed to improve patients' quality of life and reduce healthcare costs by $6,000 per patient. The company primarily targets patients with chronic obstructive pulmonary disease (COPD) and other chronic lung conditions, providing a convenient and effective alternative to traditional in-person rehab.
Notable figures affiliated with Kivo Health include experienced healthcare professionals and telehealth innovators. The company has achieved significant milestones, such as a 45% increase in patient activity levels and substantial cost savings for payers. Kivo Health's impact is profound, addressing the gap where only 3% of eligible patients currently receive necessary therapy, thereby enhancing patient outcomes and contributing to the broader adoption of telehealth in pulmonary care.
